Bellerophon Therapeutics Presents Late-Breaking Poster at the European Society of Cardiology's Heart Failure 2015/2nd World Congress on Acute Heart Failure
May 27, 2015 07:20 ET
|
Bellerophon Therapeutics LLC
HAMPTON, N.J., May 27, 2015 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced positive results from a recent pig study...
Bellerophon Therapeutics Adds to Experienced Drug and Device Development Management Team
May 20, 2015 07:03 ET
|
Bellerophon Therapeutics LLC
HAMPTON, N.J., May 20, 2015 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, LLC (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced that it has further strengthened its management...
Bellerophon Reports 2015 First Quarter Financial and Operational Results
May 15, 2015 16:07 ET
|
Bellerophon Therapeutics LLC
HAMPTON, N.J., May 15, 2015 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today reported financial results for the first quarter ended...
Bellerophon Therapeutics Appoints Two New Independent Board Members
May 13, 2015 07:03 ET
|
Bellerophon Therapeutics LLC
HAMPTON, N.J., May 13, 2015 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced the appointments of Scott P. Bruder, M.D., Ph.D....
Bellerophon Therapeutics Forms Scientific Advisory Board for INOpulse(R) Programs
May 07, 2015 07:03 ET
|
Bellerophon Therapeutics LLC
HAMPTON, N.J., May 7, 2015 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced the formation of an INOpulse® Scientific...
Bellerophon Therapeutics to Present Late-Breaking Poster at the European Society of Cardiology's Heart Failure 2015/2nd World Congress on Acute Heart Failure
May 05, 2015 08:03 ET
|
Bellerophon Therapeutics LLC
HAMPTON, N.J., May 5, 2015 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced that it will present results from a recent pig...
Bellerophon Reports 2014 Full Year Financial and Operational Results
March 31, 2015 06:30 ET
|
Bellerophon Therapeutics LLC
HAMPTON, N.J., March 31, 2015 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today reported financial results for the year ended December...
Bellerophon Therapeutics Selects Flextronics to Manufacture the Mark2, Next-Generation INOpulse(R) Device
March 25, 2015 06:05 ET
|
Bellerophon Therapeutics LLC
HAMPTON, N.J., March 25, 2015 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced that it has selected Flextronics International...
Bellerophon Therapeutics to Ring the NASDAQ Stock Market Closing Bell
March 16, 2015 16:44 ET
|
Bellerophon Therapeutics LLC
HAMPTON, N.J., March 16, 2015 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, LLC (Nasdaq:BLPH) a clinical stage biotherapeutics company, today announced that it will preside over the ceremonial NASDAQ...
Bellerophon Therapeutics Announces Closing of Its Initial Public Offering
February 19, 2015 17:30 ET
|
Bellerophon Therapeutics LLC
Hampton, N.J., Feb. 19, 2015 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH) announced today the closing of its initial public offering of 5,000,000 shares of common stock at a public...